Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul;55(7):1547-1557.
doi: 10.1007/s40279-025-02232-3. Epub 2025 May 21.

Potential Short- and Long-Term Physiological Effects of Ischemic Preconditioning as an Ergogenic Aid: Revisiting Foundational Mechanisms and Applications

Affiliations
Review

Potential Short- and Long-Term Physiological Effects of Ischemic Preconditioning as an Ergogenic Aid: Revisiting Foundational Mechanisms and Applications

Moacir Marocolo et al. Sports Med. 2025 Jul.

Abstract

Ischemic preconditioning (IPC) has emerged as a promising intervention for enhancing health- and exercise-related outcomes. Initially recognized in the 1980s and 1990s for its cardioprotective effects in clinical and animal studies, IPC has since garnered attention for its potential ergogenic benefits. Despite growing interest, the underlying physiological mechanisms remain poorly understood, leading to research exploring cause-effect relationship and evaluating IPC efficacy across diverse exercise models, often yielding mixed results. This Leading Article aims to clarify proposed mechanisms by which IPC may enhance athletic performance and facilitate healing effects. Specifically, this Leading Article discusses both the immediate (short-term) and sustained (long-term) effects of IPC. Short-term effects primarily involve acute improvements in vascular function and exercise capacity, while long-term effects may include cumulative benefits such as enhanced recovery, mitigation of exercise-induced muscle damage and adaptative physiological responses. This article highlights the importance of optimizing experimental protocols by extending the time window between IPC application and testing, to maximize performance outcomes, particularly under conditions associated with muscle damage. Future research should prioritize exploring the long-term effects of IPC on performance and recovery to better understand its potential as a reliable ergogenic aid.

PubMed Disclaimer

Conflict of interest statement

Declarations. Funding: MM is supported by CAPES/Alexander von Humboldt Foundation Research fellow and National Council for Scientific and Technological Development – CNPq (process no. 308138/2022–8). The authors gratefully acknowledge the support provided by Ruhr University Bochum during the development of this study. Conflict of interest: The authors have no competing interests to declare that are relevant to the content of this article. Availability of data and material: Not applicable. Ethics approval: Not applicable. Consent to participate: Not applicable. Consent for publication: Not applicable. Code availability: Not applicable. Author contributions: MM and AF contributed to the study conception. MM and HLRS wrote the first draft. MM, HLRS, PS, and AF reviewed the manuscript and technically contributed to the quality of the manuscript. AF supervised the study. All authors read and approved the final version of the manuscript.

Figures

Fig. 1
Fig. 1
Proposed mechanisms by which IPC could improve athletic performance and recovery. The left side of the figure depicts short-term effects encompassing alterations in bottom-up afferent and increases in top-down efferent drive by cuff-pressure, enhancements of red blood cells deformability as well as vasodilation-inducing vasoactive substances, optimizing blood flow in the microcirculation and facilitating a greater supply of oxygen and nutrients, as well as the removal of CO2 and metabolic waste. The right side of the figure outlines the long-term effects, which are associated with a signaling cascade that increases mitochondrial activity while reducing oxidative stress and the inflammatory response. The sequential occurrence of these factors could mitigate EIMD and accelerate the healing process, thereby optimizing athletic performance. Notably, short-term vascular effects (10), although transient, could enhance EIMD healing in a post-exercise condition. EIMD exercise-induced muscle damage, IPC ischemic preconditioning, ROS reactive oxidative species

Similar articles

  • Prescription of Controlled Substances: Benefits and Risks.
    Preuss CV, Kalava A, King KC. Preuss CV, et al. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
  • Elbow Fractures Overview.
    Waseem M, Saeed W, Launico MV. Waseem M, et al. 2025 Jul 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 28723005 Free Books & Documents.
  • Short-Term Memory Impairment.
    Cascella M, Al Khalili Y. Cascella M, et al. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
  • The Effects of Ischemic Preconditioning on Human Exercise Performance.
    Incognito AV, Burr JF, Millar PJ. Incognito AV, et al. Sports Med. 2016 Apr;46(4):531-44. doi: 10.1007/s40279-015-0433-5. Sports Med. 2016. PMID: 26645697
  • Management of urinary stones by experts in stone disease (ESD 2025).
    Papatsoris A, Geavlete B, Radavoi GD, Alameedee M, Almusafer M, Ather MH, Budia A, Cumpanas AA, Kiremi MC, Dellis A, Elhowairis M, Galán-Llopis JA, Geavlete P, Guimerà Garcia J, Isern B, Jinga V, Lopez JM, Mainez JA, Mitsogiannis I, Mora Christian J, Moussa M, Multescu R, Oguz Acar Y, Petkova K, Piñero A, Popov E, Ramos Cebrian M, Rascu S, Siener R, Sountoulides P, Stamatelou K, Syed J, Trinchieri A. Papatsoris A, et al. Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.

References

    1. Sharma V, Marsh R, Cunniffe B, Cardinale M, Yellon DM, Davidson SM. From protecting the heart to improving athletic performance—the benefits of local and remote ischaemic preconditioning. Cardiovasc Drugs Ther. 2015;29(6):573–88. - PMC - PubMed
    1. Stokfisz K, Ledakowicz-Polak A, Zagorski M, Zielinska M. Ischaemic preconditioning—current knowledge and potential future applications after 30 years of experience. Adv Med Sci. 2017;62(2):307–16. - PubMed
    1. Incognito AV, Burr JF, Millar PJ. The effects of ischemic preconditioning on human exercise performance. Sports Med. 2016;46(4):531–44. - PubMed
    1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124–36. - PubMed
    1. Kida M, Fujiwara H, Ishida M, Kawai C, Ohura M, Miura I, et al. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation. 1991;84(6):2495–503. - PubMed

LinkOut - more resources